Clinical Trial Update: Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial evaluating the combination of chemoradiation therapy with an epitope peptide vaccine for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Chemoradiation therapy (chemoradiation therapy)
• Epitope peptide vaccine therapy (epitope peptide vaccine therapy)

Snippet

Sponsor: Teikyo University | Conditions: Esophageal Cancer | Phase 1 | Status: UNKNOWN